MIRA Pharmaceuticals, Inc. Common Stock (MIRA NASDAQ) stock market data APIs
$0.7564
0.02(2.6%)
as of August 13, 2026
Try our APIs with
free plan!
MIRA Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Prev. Close
0.7564
Open
0.7738
High
0.826
Low
0.7549
52 wk Range
0.6-2.45
Market Cap
31 042 K
Shares Outstanding
42 022 K
EPS
-0.03
Beta
1.551
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with MIRA Pharmaceuticals, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MIRA Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get MIRA Pharmaceuticals, Inc. Common Stock Fundamental Data
MIRA Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get MIRA Pharmaceuticals, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: NaN
Get MIRA Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MIRA Pharmaceuticals, Inc. Common Stock News
New
MIRA Pharmaceuticals Reports Positive Toxicokinetic Data For SKNY-1 In Obesity
(RTTNews) - MIRA Pharmaceuticals Inc. (MIRA), a clinical-stage pharmaceutical company, on Thursday reported positive toxicokinetic data for SKNY-1 to facilitate future studies as a GLP-1 drug with pot...
Clockwork.ai Launches Mira: The AI Giving 3,000+ Businesses a CFO They Could Never Afford
Founded in 2018, Clockwork pioneered AI forecasting for small and medium sized businesses. Now it adds Mira, an agentic analyst that runs forecasts, builds scenarios, and explains the numbers straight...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Aurora Cannabis Announced Refocused Strategy as Global Medical Sales Hit Record High in 2026 Third Quarter Canopy Growth Reported Mixed Results in its Fiscal Third Quar...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Verano Holdings Ended Legal Battle with Vireo Growth; The Company Also Reported Third Quarter 2025 Financial Results Jushi Holdings’ Subsidiary is Targeting DoorDash ...
Get MIRA Pharmaceuticals, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
